{"id":"https://openalex.org/A5060979099","orcid":"https://orcid.org/0000-0003-2511-0479","observed_orcids":["https://orcid.org/0000-0003-2511-0479"],"display_name":"Zahraa Al-Dujaili","raw_author_names":["Zahraa Al-Dujaili","Zahraa Mohammed Al-Dujaili"],"full_name":"Zahraa Mohammed Al-Dujaili","works_count":5,"cited_by_count":65,"summary_stats":{"2yr_mean_citedness":1.0,"h_index":2,"i10_index":1},"ids":{"openalex":"https://openalex.org/A5060979099","orcid":"https://orcid.org/0000-0003-2511-0479","observed_orcids":["https://orcid.org/0000-0003-2511-0479"]},"affiliations":[{"institution":{"id":"https://openalex.org/I4396570604","ror":"https://ror.org/033jerz55","display_name":"American University of Iraq Baghdad","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4396570604"]},"years":[2024,2023]}],"last_known_institutions":[{"id":"https://openalex.org/I4396570604","ror":"https://ror.org/033jerz55","display_name":"American University of Iraq Baghdad","country_code":"IQ","type":"education","lineage":["https://openalex.org/I4396570604"]}],"topics":[{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","count":2,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","count":2,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10063","display_name":"Nanoparticle-Based Drug Delivery","count":1,"subfield":{"id":"https://openalex.org/subfields/2502","display_name":"Biomaterials"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10086","display_name":"Alzheimer's disease research and treatments","count":1,"subfield":{"id":"https://openalex.org/subfields/2804","display_name":"Cellular and Molecular Neuroscience"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"topic_share":[{"id":"https://openalex.org/T14089","display_name":"Nanotechnology research and applications","value":1.6e-05,"subfield":{"id":"https://openalex.org/subfields/2500","display_name":"General Materials Science"},"field":{"id":"https://openalex.org/fields/25","display_name":"Materials Science"},"domain":{"id":"https://openalex.org/domains/3","display_name":"Physical Sciences"}},{"id":"https://openalex.org/T13633","display_name":"Public Health and Social Inequalities","value":9.4e-06,"subfield":{"id":"https://openalex.org/subfields/3306","display_name":"Health"},"field":{"id":"https://openalex.org/fields/33","display_name":"Social Sciences"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10496","display_name":"Pharmaceutical Practices and Patient Outcomes","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/2717","display_name":"Geriatrics and Gerontology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10537","display_name":"Attention Deficit Hyperactivity Disorder","value":7.2e-06,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T13970","display_name":"Pharmacy and Medical Practices","value":4.9e-06,"subfield":{"id":"https://openalex.org/subfields/3611","display_name":"Pharmacy"},"field":{"id":"https://openalex.org/fields/36","display_name":"Health Professions"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"x_concepts":[{"id":"104863432","wikidata":"https://www.wikidata.org/wiki/Q614304","display_name":"Pharmacy","score":0.8469773530960083},{"id":"71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","score":0.7886343002319336},{"id":"10446079","wikidata":"https://www.wikidata.org/wiki/Q155491","display_name":"Clinical pharmacy","score":0.5269083380699158},{"id":"118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","score":0.3814483880996704},{"id":"126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","score":0.17560487985610962}],"counts_by_year":[{"year":2019,"works_count":1,"oa_works_count":0,"cited_by_count":0},{"year":2023,"works_count":2,"oa_works_count":1,"cited_by_count":3},{"year":2024,"works_count":2,"oa_works_count":1,"cited_by_count":24},{"year":2025,"works_count":0,"oa_works_count":0,"cited_by_count":20},{"year":2026,"works_count":0,"oa_works_count":0,"cited_by_count":18}],"display_name_alternatives":["Zahraa Al-Dujaili","Zahraa Mohammed Al-Dujaili"],"block_key":"z al-dujaili","works_api_url":"https://api.openalex.org/works?filter=author.id:A5060979099","awards_count":0,"awards_api_url":"https://api.openalex.org/awards?filter=investigators.author.id:A5060979099","updated_date":"2026-11-12T13:17:38","created_date":"2020-04-17T00:00:00"}